Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 545

Results For "US"

7530 News Found

India is dedicated to ensure health Security for every citizen: Mandaviya
Policy | June 08, 2022

India is dedicated to ensure health Security for every citizen: Mandaviya

States have an important role in ensuring food safety and healthy food practices.


Novartis Scemblix shows better result for chronic myeloid leukemia trial
Diagnostic Center | June 08, 2022

Novartis Scemblix shows better result for chronic myeloid leukemia trial

Scemblix (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif (bosutinib) at 96 weeks


Agilent to improve analysis speeds of genomics bioinformatics
Digitisation | June 08, 2022

Agilent to improve analysis speeds of genomics bioinformatics

Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data


Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
News | June 07, 2022

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market

The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price


Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform
News | June 07, 2022

Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform

Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues


NewAmsterdam Pharma shares new data from Phase 2b ROSE Study
News | June 07, 2022

NewAmsterdam Pharma shares new data from Phase 2b ROSE Study

82.5% of patients treated at 10mg dose of obicetrapib achieved LDL-c target of <70 mg/dL, compared to 20% of patients treated with placebo


MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
News | June 07, 2022

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients


PM-JAY public dashboard gets revamped with new features
News | June 07, 2022

PM-JAY public dashboard gets revamped with new features

The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress


Lonza launches new non-endotoxin pyrogen detection system
News | June 07, 2022

Lonza launches new non-endotoxin pyrogen detection system

The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics


Merck’s pembrolizumab demonstrates improvement in distant metastasis
News | June 06, 2022

Merck’s pembrolizumab demonstrates improvement in distant metastasis

Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).